{"title":"Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes.","authors":"H J Ristow","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Epidermal growth factor (EGF) and insulin are the most widely used growth factors (GFs) in human keratinocyte cultures. Insulin is supposed to exert its growth-promoting activity in this system through the insulin-like growth factor-I (IGF-I) receptor. In order to obtain more information about the contribution of EGF and IGF-I to the proliferation of keratinocytes, the effect of each factor on DNA synthesis was studied with 3H thymidine incorporation in an otherwise GF-free system. Both factors are able to initiate DNA synthesis, DNA synthesis peaks 18-20 h after the addition of each factor, and neither factor influences significantly the binding of the other to the respective receptor. IGF-I is the more potent growth factor, and IGF-I-stimulated cells enter the S-phase regularly approximately 3 h earlier than EGF-stimulated keratinocytes (7-9 h vs 10-12 h). However, IGF-I-stimulated DNA synthesis can be completely turned off by the addition of the monoclonal antibody (mAb) to the EGF receptor LA1. This inhibition cannot be reversed by higher IGF-I concentrations, but only by the addition of EGF to the culture medium. These results may suggest the presence of two keratinocyte populations, one responding to EGF and one to IGF-I, with an additional signal from the EGF receptor, or they may be explained on the basis of only one cell population for which EGF acts as a \"competence' factor and IGF-I as a \"progression' factor.</p>","PeriodicalId":77148,"journal":{"name":"Growth regulation","volume":"6 2","pages":"96-109"},"PeriodicalIF":0.0000,"publicationDate":"1996-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Growth regulation","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Epidermal growth factor (EGF) and insulin are the most widely used growth factors (GFs) in human keratinocyte cultures. Insulin is supposed to exert its growth-promoting activity in this system through the insulin-like growth factor-I (IGF-I) receptor. In order to obtain more information about the contribution of EGF and IGF-I to the proliferation of keratinocytes, the effect of each factor on DNA synthesis was studied with 3H thymidine incorporation in an otherwise GF-free system. Both factors are able to initiate DNA synthesis, DNA synthesis peaks 18-20 h after the addition of each factor, and neither factor influences significantly the binding of the other to the respective receptor. IGF-I is the more potent growth factor, and IGF-I-stimulated cells enter the S-phase regularly approximately 3 h earlier than EGF-stimulated keratinocytes (7-9 h vs 10-12 h). However, IGF-I-stimulated DNA synthesis can be completely turned off by the addition of the monoclonal antibody (mAb) to the EGF receptor LA1. This inhibition cannot be reversed by higher IGF-I concentrations, but only by the addition of EGF to the culture medium. These results may suggest the presence of two keratinocyte populations, one responding to EGF and one to IGF-I, with an additional signal from the EGF receptor, or they may be explained on the basis of only one cell population for which EGF acts as a "competence' factor and IGF-I as a "progression' factor.
表皮生长因子(EGF)和胰岛素是人类角化细胞培养中应用最广泛的生长因子(GFs)。胰岛素被认为是通过胰岛素样生长因子- i (IGF-I)受体在该系统中发挥其促生长活性。为了获得更多关于EGF和IGF-I对角质形成细胞增殖的贡献的信息,在不含gf的系统中,用3H胸腺嘧啶掺入研究了每个因子对DNA合成的影响。这两种因子都能启动DNA合成,每一种因子在加入后18-20 h DNA合成达到顶峰,并且没有一种因子对另一种因子与各自受体的结合产生显著影响。IGF-I是更有效的生长因子,IGF-I刺激的细胞比EGF刺激的角质形成细胞提前约3小时进入s期(7-9小时vs 10-12小时)。然而,通过在EGF受体LA1上添加单克隆抗体(mAb), IGF-I刺激的DNA合成可以完全关闭。这种抑制不能通过更高的IGF-I浓度来逆转,而只能通过在培养基中添加EGF来逆转。这些结果可能表明存在两种角质细胞群,一种对EGF有反应,另一种对IGF-I有反应,并有来自EGF受体的额外信号,或者它们可能只基于一种细胞群,其中EGF作为“能力”因子,而IGF-I作为“进展”因子。